In cervical cancer, a study suggested that the glycolytic process is targeted, programmed cell death protein 1 (PD-1) expression is facilitated, and macrophage phagocytic function is inhibited by high expression of the m6A regulator METTL14, which accelerates cancer progression [284]. This evidence concerns the gene METTL14 and cervical carcinoma.